Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00094523
Status:
COMPLETED
Last Update Posted:
2018-04-18
First Post:
2004-10-20
Brief Title:
Fosamprenavir Versus Other Protease Inhibitors
Sponsor:
ViiV Healthcare
Organization:
ViiV Healthcare
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Infection Human Immunodeficiency Virus I |
Keywords:
| Name | View |
|---|---|
| fosamprenavir LEXIVA non-inferiority safety tolerability | View |